When you need a reproducible, CiPA-validated, in vitro model for cardiotoxicity screening that’s ready in under a week, you need these human iPSC derived cardiomyocytes.
Check out the data from testing Axol Bisocience’s ventricular cardiomyocytes with the 28 CiPA compounds using Voltage Sensitive Dyes (VSD).